Chonluten Reconstitution Calculator
Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.
What amount do you need?
Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.
Syringe size:
Possible vial strengths:
Best Match
Good Match
Usable
Harder to Measure
Example Chonluten Titration Schedule
| Week | Daily Dose | Injection Volume |
|---|---|---|
| Weeks 1–2 | 250 mcg (0.25 mg) | 3.75 units (0.0375 mL) |
| Weeks 3–4 | 500 mcg (0.5 mg) | 7.5 units (0.075 mL) |
| Weeks 5–6 | 1,000 mcg (1 mg) | 15 units (0.15 mL) |
| Weeks 7–8 | 1,500 mcg (1.5 mg) | 22.5 units (0.225 mL) |
| Weeks 9–10 | 2,000 mcg (2 mg) | 30 units (0.30 mL) |
| Weeks 11–12 | 3,000 mcg (3 mg) | 45 units (0.45 mL) |
| Weeks 13–14 | 4,000 mcg (4 mg) | 60 units (0.60 mL) |
| Weeks 15–16 | 4,000 mcg (4 mg) | 60 units (0.60 mL) |
Possible vial strengths:
What Is It?
Chonluten
Bronchial bioregulator peptide.
Bacteriostatic Water
Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.
How To Mix Chonluten
1
CleanUse alcohol swabs to clean the tops of both vials.
2
Draw BAC WaterDraw the selected amount of bacteriostatic water.
3
Inject SlowlyAdd the liquid slowly down the side of the vial.
4
Swirl GentlyDo not shake. Swirl gently until dissolved.
5
Store ProperlyStore as directed and protect from heat and light.
Best Practices & Common Mistakes
Best Practices
- Use sterile technique.
- Protect from light and heat.
- Store refrigerated when appropriate.
- Use clean syringe-unit math before measuring.
Common Mistakes
- Confusing milligrams with milliliters.
- Choosing an option with awkward decimal units.
- Using too little liquid for very small measurements.
- Shaking the vial aggressively.
Chonluten Storage & Handling
Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.
Frequently Asked Questions
Chonluten is a Khavinson "bioregulator" — a synthetic tripeptide (Glu-Asp-Gly, EDG) developed in Russia to target the mucous lining of the bronchi and lungs at the gene level. It's described as acting on respiratory epithelial cells to calm stress and inflammation genes and normalize mucus-producing cells. It's sold as an oral/sublingual capsule and as a research-grade injectable powder.
Both are Khavinson respiratory peptides but they hit different targets: Chonluten (EDG, a tripeptide) works mainly on stress-response and antioxidant genes (c-Fos, HSP70, SOD, COX-2, TNF-α) in the bronchial mucosa, while Bronchogen (AEDL, a tetrapeptide) switches on epithelial-differentiation and mucin genes (NKX2-1, MUC5AC). They're often paired in Russian COPD protocols precisely because they cover complementary parts of the airway, not because they're interchangeable.
In animal and cell studies, Chonluten is reported to reduce airway inflammation, curb excess mucus by normalizing goblet-cell activity, and restore cilia movement for clearance — with Khavinson's group also floating it for post-infection and viral lung damage. The mechanism is framed as epigenetic, dialing down stress and inflammatory genes in respiratory tissue. This is preclinical, largely Russian data, so it is not a proven treatment for asthma, COPD, or any lung disease.
Only the injectable research powder is mixed — the oral or sublingual capsule (around 200–400 mcg per dose) is taken directly. For a 20 mg vial, adding 5 mL of bacteriostatic water gives 4 mg/mL, so a 400 mcg amount draws to 0.1 mL (10 units on a U-100 syringe). Khavinson respiratory protocols run in short pulses (roughly 1–2 mg/day for ~10 days, twice a year), and no injectable human dose is formally established, so treat any number as a research figure.
Chonluten is not approved for human use in any major jurisdiction — it's a research compound or Russian-market supplement, and all safety observations come from Khavinson's own group rather than independent review. A small tripeptide is expected to be low-toxicity, but breathing problems (asthma flares, chronic bronchitis, COPD) can be dangerous to self-manage, so they warrant real respiratory care rather than an unproven peptide. Storage: keep the lyophilized powder cold and dry away from light, and once reconstituted, keep it refrigerated and use it within a few days.
Practical takeaway: If your real goal is weight or metabolic health, the most useful next step is discussing approved treatment options with a clinician rather than relying on an unapproved compound.
Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.